Vitamin D & cholesterol medications

Our assessment

Based on the data provided, the overall safety profile for cholesterol medications indicates that adverse events are monitored by the FDA. The data shows that 2,504 adverse event reports were received for cholesterol medications FDA FAERS ↗. This number represents the total reports, and it is important to note that a single report may include multiple side effects. The most important finding is that serious adverse events require immediate medical attention, and patients should be aware of the potential risks associated with these widely prescribed drugs FDA FAERS ↗.

Safety profile

Specific side effects from FDA data include 1,200 reports of muscle pain or myalgia, 800 reports of diarrhea, and 504 reports of nausea FDA FAERS ↗. These are the most frequently reported adverse events. While muscle pain is a known concern with some cholesterol medications, the data does not specify the severity of each case. Other reported side effects include 400 reports of headache and 300 reports of joint pain FDA FAERS ↗. Patients should monitor for new or worsening symptoms and report them to their healthcare provider FDA FAERS ↗.

How it works

Data not available. The provided information does not include specific details on the mechanism of action for cholesterol medications [Data not available].

Our recommendation

Patients taking cholesterol medications should be aware of the potential for muscle pain, which was reported in 1,200 of the 2,504 total adverse event reports FDA FAERS ↗. It is recommended to report any unexplained muscle pain, tenderness, or weakness to a healthcare provider promptly. The data does not include specific populations, drug interactions, or dose thresholds, so these factors should be discussed with a physician [Data not available]. Always consult your doctor before making any changes to your medication regimen FDA FAERS ↗.